ATE551065T1 - Zusammensetzungen mit igbpma und ihre verwendungen - Google Patents

Zusammensetzungen mit igbpma und ihre verwendungen

Info

Publication number
ATE551065T1
ATE551065T1 AT06808355T AT06808355T ATE551065T1 AT E551065 T1 ATE551065 T1 AT E551065T1 AT 06808355 T AT06808355 T AT 06808355T AT 06808355 T AT06808355 T AT 06808355T AT E551065 T1 ATE551065 T1 AT E551065T1
Authority
AT
Austria
Prior art keywords
igbpma
compositions containing
activation
agents
ticks
Prior art date
Application number
AT06808355T
Other languages
English (en)
Inventor
Hui Wang
Patricia Nuttall
Original Assignee
Natural Environment Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natural Environment Res Council filed Critical Natural Environment Res Council
Application granted granted Critical
Publication of ATE551065T1 publication Critical patent/ATE551065T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Insects & Arthropods (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
AT06808355T 2005-11-01 2006-10-26 Zusammensetzungen mit igbpma und ihre verwendungen ATE551065T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0522298.9A GB0522298D0 (en) 2005-11-01 2005-11-01 Agents that bind IgE
PCT/GB2006/003986 WO2007051975A2 (en) 2005-11-01 2006-10-26 Compositions comprising igbpma and uses thereof

Publications (1)

Publication Number Publication Date
ATE551065T1 true ATE551065T1 (de) 2012-04-15

Family

ID=35516154

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06808355T ATE551065T1 (de) 2005-11-01 2006-10-26 Zusammensetzungen mit igbpma und ihre verwendungen

Country Status (7)

Country Link
US (1) US8343504B2 (de)
EP (1) EP1978990B1 (de)
JP (1) JP5123858B2 (de)
CN (1) CN101351216B (de)
AT (1) ATE551065T1 (de)
GB (1) GB0522298D0 (de)
WO (1) WO2007051975A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2230934T3 (da) 2007-12-14 2012-11-26 Aerodesigns Inc Afgivelse af aerosoliserbare næringsmiddelprodukter
GB201203337D0 (en) 2012-02-24 2012-04-11 Natural Environment Res Council Method
CN110567787A (zh) * 2019-09-12 2019-12-13 浙江工商大学 一种快速纯化血清中IgG和IgE的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9406708D0 (en) 1994-04-05 1994-05-25 Mallinckrodt Veterinary Inc Vaccines
WO1997044451A2 (en) 1996-05-18 1997-11-27 Oxford Vacs Ltd. Vasoactive amine binding molecules
WO2001058941A1 (en) * 2000-02-11 2001-08-16 Evolutec Limited Cytokine activity regulator molecules from tick salivary glands
WO2002094228A1 (en) * 2001-05-23 2002-11-28 David Follansbee Prevention and treatment of allergies by helminthic regulation of ige
GB0307544D0 (en) 2003-04-01 2003-05-07 Evolutec Ltd Treatment method
US7393660B2 (en) * 2003-12-24 2008-07-01 Laboratoires Serono Sa CC-chemokine binding tick proteins

Also Published As

Publication number Publication date
JP5123858B2 (ja) 2013-01-23
CN101351216B (zh) 2014-07-16
EP1978990B1 (de) 2012-03-28
US8343504B2 (en) 2013-01-01
JP2009519213A (ja) 2009-05-14
GB0522298D0 (en) 2005-12-07
EP1978990A2 (de) 2008-10-15
US20080280828A1 (en) 2008-11-13
WO2007051975A3 (en) 2007-06-28
CN101351216A (zh) 2009-01-21
WO2007051975A2 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
ATE527365T1 (de) Il-15r alpha -sushi domäne als selektiver und effizienter verstärker der il-15-wirkung durch il-15rbeta/gamma , in hyperagonist il-15 ralpha sushi -il 15 fusionsproteine .
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
ATE481984T1 (de) Vakzine-peptid-kombinationen gegen katzenallergie
EA201000888A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов
ATE529442T1 (de) Verbesserte humane interferon-moleküle und ihre verwendungen
ATE471334T1 (de) Phosphoramidatderivate von nukleosidverbindungen zur verwendung bei der behandlung von krebs
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
ATE541928T1 (de) Inhibitoren der untereinheit 2 der ribonukleotidreduktase und ihre verwendungen
ECSP109956A (es) Composiciones y métodos para controlar nemátodos
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
EA201100158A1 (ru) Антагонисты активина-actriia и их применение для стимулирования роста кости
DE602006010401D1 (de) Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen
MX2010000594A (es) Pesticidas y usos de los mismos.
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
WO2006133134A3 (en) Compositions comprising elemental metals and uses therefor
CR11126A (es) Inhibicion de metastasis de tumor por anticuerpos anti neuropilina 2
ATE460923T1 (de) Lyophilisierung von virosomen
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
MX2008001538A (es) Aril piridinas y metodos para su uso.
TW200833248A (en) Bisoximes as fungicides
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
PL1922128T3 (pl) Element do zmniejszania zawartości drobnego pyłu w powietrzu, za pomocą mchów i/lub porostów
AR032548A1 (es) Metodo y composicion para desinfectar una superficie contaminada con una proteina prion
EA200970419A1 (ru) Микроциклические хиназолиновые производные в качестве ингибиторов vegfr3